Jeffrey Szer

MDS-134: Efficacy and Safety at 48 Weeks of Pegcetacoplan in Adult Paroxysmal Nocturnal Hemoglobinuria Patients with Suboptimal Response to Prior Eculizumab Treatment

Ilene C Weitz, Régis Peffault de Latour, Jeffrey Szer, Alexander Roth, Britta Höchsmann, Jens Panse, Kensuke Usuki, Morag Griffin, Jean-Jacques Kiladjian, Carlos M de Castro, Hisakazu Nishimori, Lisa Tan, Mohammed Al-Adhami, Pascal Deschatelets, Cedric Francois, Federico Grossi, Antonio Risitano, Peter Hillmen

Journal article  |  2021  |  Clinical Lymphoma Myeloma and Leukemia

Poster: MDS-134: Efficacy and Safety at 48 Weeks of Pegcetacoplan in Adult Paroxysmal Nocturnal Hemoglobinuria Patients with Suboptimal Response to Prior Eculizumab Treatment

Ilene C Weitz, Régis Peffault De Latour, Jeffrey Szer, Alexander Röth, Britta Höchsmann, Jens Panse, Kensuke Usuki, Morag Griffin, Jean-Jacques Kiladjian, Carlos M de Castro, Hisakazu Nishimori, Lisa Tan, Mohammed Al-Adhami, Pascal Deschatelets, Cedric Francois, Federico Grossi, Antonio Risitano, Peter Hillmen

Journal article  |  2021  |  Clinical Lymphoma Myeloma and Leukemia

Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improves Transplant Outcomes in Older MDS Patients.

Betul Oran, Kwang Woo Ahn, Caitrin Fretham, Amer Beitinjaneh, Asad Bashey, Attaphol Pawarode, Baldeep Wirk, Bart L Scott, Bipin N Savani, Christopher Bredeson, Daniel Weisdorf, David I Marks, David Rizzieri, Edward Copelan, Gerhard C Hildebrandt, Gregory A Hale, Hemant S Murthy, Hillard M Lazarus, Jan Cerny, Jane L Liesveld, et al.

Journal article  |  2021  |  Transplant Cell Ther

Reduced-intensity conditioning (RIC) regimens developed to extend allogeneic stem cell transplantation (HSCT) to older patients ha..

One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors.

Dietger Niederwieser, Helen Baldomero, Nosa Bazuaye, Caitrin Bupp, Naeem Chaudhri, Selim Corbacioglu, Alaa Elhaddad, Cristóbal Frutos, Sebastian Galeano, Nada Hamad, Amir Ali Hamidieh, Shahrukh Hashmi, Aloysius Ho, Mary M Horowitz, Minako Iida, Gregorio Jaimovich, Amado Karduss, Yoshihisa Kodera, Nicolaus Kröger, Regis Péffault de Latour, et al.

Journal article  |  2021  |  Haematologica

The Worldwide Network of Blood and Marrow Transplantation (WBMT) pursues the mission of promoting hematopoietic cell transplantati..

COVID-19: looking backward

Ian Woolley, Daniel Steinfort, Jeff Szer

Journal article  |  2021  |  INTERNAL MEDICINE JOURNAL

COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement

Georgia McCaughan, Pietro Di Ciaccio, Michelle Ananda-Rajah, Nicole Gilroy, Raina MacIntyre, Benjamin Teh, Robert Weinkove, Jennifer Curnow, Jeff Szer, Anoop K Enjeti, David M Ross, Stephen Mulligan, Judith Trotman, Michael Dickinson, Hang Quach, Phillip Choi, Mark N Polizzotto, Constantine S Tam, P Joy Ho, Matthew Ku, et al.

Journal article  |  2021  |  INTERNAL MEDICINE JOURNAL

Australia and New Zealand have achieved excellent community control of COVID-19 infection. In light of the imminent COVID-19 vacci..

Hematological manifestations and complications of Gaucher disease

Shoshana Revel-Vilk, Jeff Szer, Ari Zimran

Journal article  |  2021  |  EXPERT REVIEW OF HEMATOLOGY

Introduction: Gaucher disease (GD), although pan-ethnic and rare (common in Ashkenazi Jews), is of great importance to hematologis..

Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria

Peter Hillmen, Jeff Szer, Ilene Weitz, Alexander Roeth, Britta Hoechsmann, Jens Panse, Kensuke Usuki, Morag Griffin, Jean-Jacques Kiladjian, Carlos de Castro, Hisakazu Nishimori, Lisa Tan, Mohamed Hamdani, Pascal Deschatelets, Cedric Francois, Federico Grossi, Temitayo Ajayi, Antonio Risitano, Regis Peffault de la Tour

Journal article  |  2021  |  NEW ENGLAND JOURNAL OF MEDICINE

BACKGROUND: Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired disease characterized by chronic complement-mediated hem..

Clinical ethics resources from the Royal Australasian College of Physicians

David Isaacs, Jeff Szer

Journal article  |  2021  |  JOURNAL OF PAEDIATRICS AND CHILD HEALTH

Changes in Hematopoietic Cell Transplantation Practices in Response to COVID-19: A Survey from the Worldwide Network for Blood & Marrow Transplantation

Nina Worel, Bronwen E Shaw, Mahmoud Aljurf, Mickey Koh, Adriana Seber, Daniel Weisdorf, Joseph Schwartz, Sebastian Galeano, Yoshihisa Kodera, Paul W Eldridge, Shahrukh Hashmi, Yoshiko Atsuta, Jeff Szer, Wael Saber, Dietger Niederwieser, Hildegard T Greinix

Journal article  |  2021  |  TRANSPLANTATION AND CELLULAR THERAPY

SARS-CoV-2 has spread rapidly worldwide, but the full impact of the COVID-19 pandemic on the field of hematopoietic cell transplan..